• No results found

18 results with keyword: 'focal choroidal excavation eyes central serous chorioretinopathy'

Focal choroidal excavation in eyes with central serous chorioretinopathy.

Beneath the focal choroidal excavation, unusual choroidal tissue, devoid of large vessels, is seen bridging the bottom of the excavation and the outer choroidal boundary

Protected

N/A

26
0
0
2021
Choroidal neovascularization emerged right from the focal choroidal excavation in eyes with central serous chorioretinopathy post half-dose photodynamic therapy: a case report

AMD: age related macular degeneration; BCVA: best-corrected visual acuity; CNV: choroidal neovascularization; CSC: central serous chorioretinopathy; FA: fluorescent angiograph;

Protected

N/A

6
0
0
2020
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis

Subfoveal choroidal thickness after photodynamic therapy in patients with acute idio- pathic central serous chorioretinopathy. Chronic central serous chorioretinopathy is

Protected

N/A

37
0
0
2021
Characteristics of Pachychoroid Diseases and Age-Related Macular Degeneration: Multimodal Imaging and Genetic Backgrounds

Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy,

Protected

N/A

38
0
0
2021
BAL 002 2(i) Disturbance Control Standard Contingency Reserve for Recovery from a Balancing Contingency Event

The Responsible Entity  achieved less than  70% of required  recovery from a  Reportable Balancing  Contingency Event  during the .

Protected

N/A

10
0
0
2021
Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy

BCVA: best corrected visual acuity; CCSCR: chronic central serous chorioretinopathy; CNV: choroidal neovascularization; CRT: central retinal thickness; CRTA: central retinal

Protected

N/A

9
0
0
2020
Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy

ASP: Automated static perimetry; BCVA: Best-corrected visual acuity; CFT: Central foveal thickness; CNV: Choroidal neovascularization; CSCR: Central serous chorioretinopathy;

Protected

N/A

6
0
0
2020
Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy

: Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.

Protected

N/A

5
0
0
2020
Diagnostic accuracy of optical coherence tomography angiography for choroidal neovascularization: a systematic review and meta-analysis

AMD: Age-related macular degeneration; CNV: Choroidal neovascularization; CSCR: Central serous chorioretinopathy; DOR: Diagnostic odds ratio; FA: Fluorescein angiography;

Protected

N/A

9
0
0
2020
Efficacy of Focal Lasers in Central Serous Chorioretinopathy

Central Serous chorioretinopathy (CSR) is an idiopathic disorder characterized by a localized and circumscribed serous detachment of the sensory retina at the macula

Protected

N/A

92
0
0
2021
Pachychoroid Diseases of the Macula

Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy. Subfoveal

Protected

N/A

5
0
0
2021
Choroidal thickness in older patients with central serous chorioretinopathy

CSCR: central serous chorioretinopathy; OCT: optical coherence tomography; RPE: retinal pigmented epithelium; ICG: indocyanine green; SD: spectral domain; PCV: polypoidal

Protected

N/A

6
0
0
2020
MPI+X - Hybrid Programming on Modern Compute Clusters with Multicore Processors and Accelerators

― Compute intensive code regions offloaded to the device, executed as kernels ; Host orchestrates data movement, initiates computation, waits for completion; Support for

Protected

N/A

220
0
0
2021
Update to Second-Quarter Procedure Code Review Updates

Is not reimbursed to radiation treatment centers, hospitals, radiological and physiological laboratories in the inpatient hospital setting. Is not reimbursed to radiation

Protected

N/A

6
0
0
2021
Navigated focal laser photocoagulation for central serous chorioretinopathy

Exclusion criteria included: any previous treatment for CSCR in the study eye; CSCR with subfoveal leak for which laser photocoagulation may not be the treatment of choice; cur-

Protected

N/A

5
0
0
2020
Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study

CSCR: chronic central serous chorioretinopathy; BCVA: best corrected visual acuity; OCT: optical coherence tomography; SRF: sub retinal fluid; CT: choroidal thickness; CMT:

Protected

N/A

7
0
0
2020
Short-term changes of choroidal vascular structures after phacoemulsification surgery

AL: Axial length; AMD: Age-related macular degeneration; CSC: Central serous chorioretinopathy; CVI: Choroidal vascularity index; EDI: Enhanced depth imaging; IOP: Intraocular

Protected

N/A

7
0
0
2020
Readme File. Purpose. New Features. Installation Updates. Software Requirements. Hyperion Smart View for Office Release Readme.

• If you have two Reporting and Analysis active connections, one of which is the default, using Refresh All in a document in the connection that is not the default may cause Excel to

Protected

N/A

17
0
0
2021

Upload more documents and download any material studies right away!